Skip to main content
SLS
NASDAQ Life Sciences

SELLAS Nears Phase 3 REGAL Trigger as Shares Jump 7%

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$12.359
Mkt Cap
$2.486B
52W Low
$1.39
52W High
$15.877
52W Position info
789% above low
Off High info
22% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

SLS has more than doubled off its 52-week low of $1.39.

Summary

SELLAS is approaching the 80-death event trigger for its pivotal Phase 3 REGAL trial, with final analysis expected soon. The stock rose 7% to $12.31 on the news, ending a three-quarter decline. Phase 2 data for SLS009 (tambiciclib) is due in Q4, adding another near-term catalyst. The company's cash position of $138.3 million from the August 10-Q provides runway through these readouts. Traders are also watching for possible deal activity given the HQ lease through September 2027.

At the time of this announcement, SLS was trading at $12.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $1.39 to $15.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

SLS - Latest Insights

SLS
Nov 12, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.01
Real-time Price: $7.38 info
Change: -$0.625 (-8%) info
Market Cap: $1.5B info
SLS
Oct 28, 2026, 8:35 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $12.75
Real-time Price: $7.38 info
Change: -$5.37 (-42%) info
Market Cap: $1.5B info
SLS
Aug 11, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $10.98
Real-time Price: $7.38 info
Change: -$3.59 (-33%) info
Market Cap: $1.5B info
SLS
Aug 11, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.97
Real-time Price: $7.38 info
Change: -$3.59 (-33%) info
Market Cap: $1.5B info
SLS
Aug 11, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.13
Real-time Price: $7.38 info
Change: -$3.75 (-34%) info
Market Cap: $1.5B info